Chesapeake Partners Management’s Zimmer Biomet ZBH Stock Holding History

Chesapeake Partners Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-51,500	Closed	-$5.88M	–	128
2015 Q1	$5.88M	Buy	+51,500	New	+$5.88M	0.27%	77

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chesapeake Partners Management's ZBH Position: Q2 2015 in Review

Chesapeake Partners Management sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 51,500 shares — an estimated $5.88M sold.

Chesapeake Partners Management first reported a position in ZBH in Q1 2015 and held it in 1 quarter. The position peaked at $5.88M in Q1 2015. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Chesapeake Partners Management reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
Chesapeake Partners Management sold 51,500 Zimmer Biomet shares in Q2 2015, an estimated $5.88M.
Chesapeake Partners Management first reported a position in Zimmer Biomet in Q1 2015 and held it in 1 quarter.
Chesapeake Partners Management's Zimmer Biomet position peaked at $5.88M in Q1 2015.
749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Chesapeake Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.